Blood lipid profiles in children with acute lymphoblastic leukemia

Cancer

Volumn 83, Issue 2, 1998, Pages 379-384

  Halton, Jacqueline M ^a,b,c   Nazir, Darius J ^a,b   McQueen, Matthew J ^a,b   Barr, Ronald D ^a,b  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Acute lymphoblastic; L asparaginase; Leukemia; Lipid metabolism

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER RISK; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ANTINEOPLASTIC AGENTS; ASPARAGINASE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; LIPID METABOLISM; LIPIDS; MALE; NUTRITIONAL STATUS;

EID: 0032527952     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980715)83:2<379::AID-CNCR24>3.0.CO;2-P     Document Type: Article

References (29)

1. Marini A, Carulli G, Azzara A, Grassi B, Ambrogi F. Serum cholesterol and triglycerides in hematological malignancies. Acta Haematol 1989;81:75-9.
2. Feinleib M. Review of the epidemiological evidence for a possible relationship between hypocholesterolaemia and cancer. Cancer Res 1983;43(3):2503-7s.
3. Alexopoulos CG, Blatsios B, Avgerinos A. Serum lipids and lipoprotein disorders in cancer patients. Cancer 1987;60: 3065-70.
4. Blackett PR, Koren E, Blackstock R, Downs D, Wang CS. Hyperlipidemia in acute lymphoblastic leukemia. Ann Clin Lab Sci 1984;14:123-9.
5. Favrot MC, Dellamonica C, Souillet G. Study of blood lipids in 30 children with a malignant hematological disease or carcinoma. Biomed Pharmacother 1984;38:55-9.
6. Spiegel RJ, Schaefer EJ, Magrath IT, Edwards BK. Plasma lipid alterations in leukemia and lymphoma. Am J Med 1982;72:775-82.
7. Baroni S, Scribano D, Pagano L, Zuppi C, Leone G, Giardina B. Lipids and lipoproteins in acute lymphoblastic leukaemia (ALL). Leuk Res 1994;18:643-4.
8. Shokunbi WA, Ahaneku JE, Okpala IE. Cholesterol, lipoprotein and phospholipid levels in acute lymphoblastic leukemia. Eur J Haematol 1991;46;59-61.
9. Parsons SK, Skapek SX, Neufeld EJ, Kuhlman C, Young ML, Donnelly M, et al. Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood 1997;89:1886-95.
10. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
11. Friberger P, Knos M, Gustavsson S, Aurell L, Claeson G. Methods for determination of plasmin, antiplasmin and plasminogen by means of substrate S-2251. Haemostasis 1978;7:138-45.
12. Hamill PV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM. Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr 1979;32:607-29.
13. National Cholesterol Education Program. Report on the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992;89:S534-5. mostasis and thrombosis. Philadelphia: J.B. Lippincott Co., 1987:943.
14. Ortega JA, Nesbit ME, Donaldson MH, Hittle RE, Weiner J, Karon M, et al. L-asparaginase, vincristine, prednisone for induction of first remission in acute lymphoblastic leukemia. Cancer Res 1977;37;535-40.
15. Sallan SE, Camitta BM, Cassady JR, Nathan DG, Frei E III. Intermittent combination chemotherapy with Adriamycin for childhood acute lymphoblastic leukemia: clinical results. Blood 1978;51:425-33.
16. Steinherz PG. Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase. Cancer 1994;74:3234-9.
17. Cremer P, Lakomek M, Beck W, Prindull G. The effect of L-asparaginase on lipid metabolism during induction chemotherapy of childhood lymphoblastic leukaemia. Eur J Pediatr 1988;147:64-7.
18. Williams RR, Sorlie PD, Feinleib M, McNamara PM, Kannal WB, Dawber TR. Cancer incidence by levels of cholesterol. JAMA 1981;245:247-52.
19. Sherwin RW, Wentworth DN, Cutler JA, Hulley SB, Kuller LH, Stamler J. Serum cholesterol levels and cancer mortality in 361, 662 men screened for the multiple risk factor intervention trial. JAMA 1987;257:943-8.
20. Noma A, Abe A, Maeda S, Seishima M, Makino K, Yano Y, et al. Lp(a): an acute-phase reactant? Chem Phys Lipids 1994; 67/68:411-7.
21. Mitchell LG, Halton JM, Vegh PA, Barr RD, Venneri T, Pai KM, et al. Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia. Am J Pediatr Hematol Oncol 1994;16:120-6.
22. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987;330:132-7.
23. Stein JH, Rosenson RS. Lipoprotein Lp(a) excess and coronary heart disease. Arch Intern Med 1997;157:1170-6.
24. Andrew M, Brooker L, Mitchell L. Acquired antithrombin III deficiency secondary to asparaginase therapy in childhood acute lymphoblastic leukemia. Blood Coagul Fibrinolysis 1994;5:S24-36.
25. Priest JR, Ramsay NKC, Latchaw RE, Lockman LA, Hasegawa DK, Coates TD, et al. Thrombotic and hemorrhagic strokes complicating early therapy for childhood acute lymphoblastic leukemia. Cancer 1980;46:1548-54.
26. Pui CH, Chesney CM, Weed J, Jackson CW. Altered von Willebrand factor molecule in children with thrombosis following asparaginase - prednisone - vincristine therapy for leukemia. J Clin Oncol 1985;3:1266-72.
27. Muller CP, Trilling B, Steinke B. The prognostic significance of total serum cholesterol in patients with Hodgkin's disease. Cancer 1992;69:1042-6.
28. Munker R, Cremer P, Fries S, Hiller E. Serum lipids in patients with Hodgkin's disease in complete remission. Acta Oncol 1997;36:75-7.
29. Cameron JL, Capuzzi DM, Zuidema GD, Margolis S. Acute pancreatitis with hyperlipidemia: evidence for a persistent defect in lipid metabolism. Am J Med 1974;56:482-7.